Multiple Sclerosis: Early Treatment With Tecfidera And Tysabri Can Improve Outcomes

Multiple Sclerosis: Early Treatment with Tecfidera and Tysabri Can Improve Outcomes

Harnessing the Full Potential of DMT Mechanisms of Action to Improve MS Outcomes

Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock

Science Communication Lab

MS Treatment 2021: We don't treat Multiple Sclerosis correctly.

Aaron Boster MD

How Does TYSABRI Treat MS?

Aaron Boster MD

Tysabri vs Tecfidera for Multiple Sclerosis. Which is Better, and Does Current Disability Matter?

Dr. Brandon Beaber

Benefits of SC natalizumab in MS

MS Drug Showdown: Which Medications are the Best?

Aaron Boster MD

Tecfidera Continues To Show Positive Results For Multiple Sclerosis Patients

Is TYSABRI for MS dangerous during COVID19 pandemic? #Shorts

Aaron Boster MD

We're Probably Going to Cure MS

The importance of early treatment in multiple sclerosis

Switching from Tysabri to Tecfidera

Pregnancy, Multiple Sclerosis, Medications, and Risk of Relapses

Dr. Brandon Beaber

Long-term efficacy outcomes of natalizumab vs. fingolimod in highly active RRMS

How Tysabri (natalizumab) Works in Relapsing Multiple Sclerosis

What are the risks and benefits of Tysabri and who should take it?

FDA Approves Tecfidera for Multiple Sclerosis Treatment

Bench to Bedside: Multiple Sclerosis and Tysabri, Part 2 - Ted Yednock

Science Communication Lab

Current and Emerging Treatment Options for MS: Personalized Medicine Strategies

The France Foundation